Back to HomeBeta

ICD-10 Coding for Secondary Immunodeficiency Disorder(D84.821, D84.89)

Complete ICD-10-CM coding and documentation guide for Secondary Immunodeficiency Disorder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Acquired ImmunodeficiencySecondary Immune Deficiency

Related ICD-10 Code Ranges

Complete code families applicable to Secondary Immunodeficiency Disorder

D80-D89Primary Range

Disorders involving the immune mechanism

This range includes codes for various immunodeficiency disorders, including secondary immunodeficiency.

Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances

This range includes codes for adverse effects of drugs, which can cause secondary immunodeficiency.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D84.821Immunodeficiency due to drugsUse when immunodeficiency is directly linked to drug therapy.
  • Documented use of immunosuppressive drugs
  • Laboratory evidence of hypogammaglobulinemia (IgG <5g/L)
D84.89Other specified immunodeficienciesUse when immunodeficiency is due to conditions like post-splenectomy or myeloma.
  • Recurrent infections with documented immunodeficiency not linked to drugs

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for drug-induced secondary immunodeficiency

Essential facts and insights about Secondary Immunodeficiency Disorder

The ICD-10 code for drug-induced secondary immunodeficiency is D84.821, used when immunodeficiency is linked to drug therapy.

Primary ICD-10-CM Codes for secondary immunodeficiency disorder

Immunodeficiency due to drugs
Billable Code

Decision Criteria

clinical Criteria

  • Patient is on immunosuppressive therapy with documented low IgG levels.

Applicable To

  • Drug-induced immunodeficiency

Excludes

  • Primary immunodeficiency disorders (D80-D83)

Clinical Validation Requirements

  • Documented use of immunosuppressive drugs
  • Laboratory evidence of hypogammaglobulinemia (IgG <5g/L)

Code-Specific Risks

  • Incorrect sequencing with drug toxicity codes

Coding Notes

  • Ensure drug causality is clearly documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Adverse effect of antineoplastic and immunosuppressive drugs

T45.1X5A
Use alongside D84.821 to indicate drug-induced immunodeficiency.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Other specified immunodeficiencies

D84.89
Use D84.89 when immunodeficiency is due to non-drug causes.

Immunodeficiency due to drugs

D84.821
Use D84.821 when immunodeficiency is directly linked to drug therapy.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Secondary Immunodeficiency Disorder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D84.821.

Impact

Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Review drug therapy history., Ensure lab results support diagnosis.

Impact

Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Always sequence the drug toxicity code before D84.821.

Impact

High risk of audit if drug causality is not documented.

Mitigation Strategy

Ensure thorough documentation of drug therapy and lab results.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Secondary Immunodeficiency Disorder, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Secondary Immunodeficiency Disorder

Use these documentation templates to ensure complete and accurate documentation for Secondary Immunodeficiency Disorder. These templates include all required elements for proper coding and billing.

Oncology patient with drug-induced immunodeficiency

Specialty: Oncology

Required Elements

  • Drug name and duration
  • IgG levels
  • Infection history

Example Documentation

Patient on rituximab for 12 months with IgG 3.5g/L and recurrent pneumonia.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has low immunoglobulins.
Good Documentation Example
Patient on rituximab for 12 months, IgG 3.5g/L, recurrent pneumonia requiring IV antibiotics.
Explanation
The good example provides specific drug information and clinical findings.

Need help with ICD-10 coding for Secondary Immunodeficiency Disorder? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more